ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 89 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $174,000 | -48.8% | 46,000 | -16.1% | 0.03% | +17.4% |
| Q2 2019 | $340,000 | -12.8% | 54,822 | 0.0% | 0.02% | -39.5% |
| Q1 2019 | $390,000 | -16.7% | 54,822 | 0.0% | 0.04% | -60.0% |
| Q4 2018 | $468,000 | -88.0% | 54,822 | -71.8% | 0.10% | -63.3% |
| Q3 2018 | $3,898,000 | -25.3% | 194,715 | -3.7% | 0.26% | -44.7% |
| Q2 2018 | $5,221,000 | -10.1% | 202,115 | -16.8% | 0.47% | -16.6% |
| Q1 2018 | $5,806,000 | -36.7% | 242,915 | -10.2% | 0.56% | -37.5% |
| Q4 2017 | $9,168,000 | +29.8% | 270,515 | -18.9% | 0.90% | -39.7% |
| Q3 2017 | $7,061,000 | +53.2% | 333,515 | +26.6% | 1.49% | +30.7% |
| Q2 2017 | $4,609,000 | +11.8% | 263,515 | +11.9% | 1.14% | -7.6% |
| Q1 2017 | $4,122,000 | -4.7% | 235,515 | -8.0% | 1.23% | -64.3% |
| Q4 2016 | $4,327,000 | +17.5% | 256,031 | +14.1% | 3.45% | +140.1% |
| Q3 2016 | $3,681,000 | +8.4% | 224,331 | 0.0% | 1.44% | -1.4% |
| Q2 2016 | $3,396,000 | +19.2% | 224,331 | +122.9% | 1.46% | +241.2% |
| Q4 2015 | $2,850,000 | +206.1% | 100,631 | +80.9% | 0.43% | -33.1% |
| Q3 2015 | $931,000 | -42.6% | 55,631 | -10.0% | 0.64% | +35.2% |
| Q2 2015 | $1,621,000 | +50.7% | 61,813 | 0.0% | 0.47% | +19.8% |
| Q1 2015 | $1,076,000 | +0.7% | 61,813 | 0.0% | 0.39% | -21.4% |
| Q4 2014 | $1,068,000 | +3.1% | 61,813 | 0.0% | 0.50% | -2.9% |
| Q3 2014 | $1,036,000 | – | 61,813 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|